FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1258939007: Product containing precisely mesalazine 1.2 gram/1 each prolonged-release oral tablet (clinical drug)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Sep 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    5155122011 Product containing precisely mesalazine 1.2 gram/1 each prolonged-release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    5155123018 Mesalazine 1.2 g prolonged-release oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    5155124012 Mesalamine 1.2 g prolonged-release oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    5155122011 Product containing precisely mesalazine 1.2 gram/1 each prolonged-release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    5155123018 Mesalazine 1.2 g prolonged-release oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    5155124012 Mesalamine 1.2 g prolonged-release oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Product containing precisely mesalazine 1.2 gram/1 each prolonged-release oral tablet (clinical drug) Is a Product containing only mesalazine in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely mesalazine 1.2 gram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form Prolonged-release oral tablet false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely mesalazine 1.2 gram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation Tablet (unit of presentation) false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely mesalazine 1.2 gram/1 each prolonged-release oral tablet (clinical drug) Has precise active ingredient Mesalazine false Inferred relationship Existential restriction modifier (core metadata concept) 1
    Product containing precisely mesalazine 1.2 gram/1 each prolonged-release oral tablet (clinical drug) Has basis of strength substance (attribute) Mesalazine false Inferred relationship Existential restriction modifier (core metadata concept) 1
    Product containing precisely mesalazine 1.2 gram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength numerator unit (attribute) g false Inferred relationship Existential restriction modifier (core metadata concept) 1
    Product containing precisely mesalazine 1.2 gram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) Tablet (unit of presentation) false Inferred relationship Existential restriction modifier (core metadata concept) 1
    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator attribute value reference set (foundation metadata concept)

    SAME AS association reference set (foundation metadata concept)

    Back to Start